Warning: session_start(): open(/home/tayedi/public_html/src/var/sessions/sess_352c3792d35875c9ce59ef8cb7b8aff7, O_RDWR) failed: No space left on device (28) in /home/tayedi/public_html/src/bootstrap.php on line 59

Warning: session_start(): Failed to read session data: files (path: /home/tayedi/public_html/src/var/sessions) in /home/tayedi/public_html/src/bootstrap.php on line 59
Ozempic maker Novo Nordisk gets another downgrade. The end’s in sight for its duopoly status, says TD Cowen. - Tayedi Search engine

Ozempic maker Novo Nordisk gets another downgrade. The end’s in sight for its duopoly status, says TD Cowen.

4 days ago 27

Novo Nordisk on Tuesday received a broker downgrade, with the analysts arguing that its status as a duopoly in both diabetes and weight loss are under threat.

Read Entire Article

Ozempic maker Novo Nordisk gets another downgrade. The end’s in sight for its duopoly status, says TD Cowen.

Related

Former UK Prime Minister Calls Bitcoin A ‘Giant Ponzi Scheme...

Bitcoin Crash Far From Over? Analyst Shares How Painful Bear...

Bitcoin Probes $73,000 Liquidity Pocket: Is The Next Leg Tow...

Trending

Popular

Singapore man gets 2-year sentence for involvement in $6.9M ...

XRP jumps 3% as breakout above $1.39 ends early-2026 downtre...

Trader swaps $50M on Aave but receives just 324 AAVE — here’...

Bitcoin Returns Mirror Late-2022 Levels Seen Before 67% Rall...

The S&P 500 just broke a major support. Another 10% decline ...

Will Markets React to $1.9B Bitcoin Options Expiring Today?

Here are 7 charts guaranteed to stress you out about the sto...

A key inflation gauge just logged its highest reading in alm...

Bitcoin 'passing geopolitical stress test' as BTC price spik...

BlackRock’s staked ether ETF draws $15 million in first-day ...